Operator Hello, and welcome to the Kenvue fourth-quarter and full-year 2024 earnings conference call. [Operator instructions] ...

Shares of Kenvue Inc. KVUE slipped 4.53% to $19.80 Thursday, on what proved to be an all-around mixed trading session for the ...

Consumer health company Kenvue forecast 2025 adjusted profit below Wall Street estimates on Thursday, hit by a stronger ...

For the quarter ended December 2024, Kenvue (KVUE) reported revenue of $3.66 billion, down 0.1% over the same period last year. EPS came in at $0.26, compared to $0.31 in the year-ago quarter. The ...

We recently published a list of 12 Best Beauty Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

Kenvue Inc. (NYSE: KVUE), today announced financial results for the full year and fiscal fourth quarter ended December 29, ...

Kenvue (KVUE) delivered earnings and revenue surprises of 0% and 2.94%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Kenvue posted mixed Q4 earnings, with in-line EPS but revenue below estimates, driven by challenges in its Skin Health and Beauty segment.

Hedge fund Starboard Value has nominated four directors, including its chief investment officer, to the board of consumer ...

Kenvue Inc. (KVUE) confirms receipt of activist Starboard Value's board nominees, aiming to unlock company's potential and ...

Kenvue is the world’s largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson’s consumer segment, Kenvue spun off and went ...

Pure-play consumer health company Kenvue Inc. (KVUE) , while reporting weak fourth-quarter profit, in line with market, on Thursday ...